Global Multiplexed Diagnostics Market: Bolstered Funding for Genomics to Bode Well for Growth, predicts TMR A handful of players dominated the otherwise fragmented global multiplexed diagnostics market in 2015. Thermo Fisher Scientific, Abbott Laboratories, and Agilent Technologies were the leaders of this market for 2015, with a collective share of 59.5% in terms of value. The market is defined by the presence of these few leaders and then the presence of a large number of small-scale and mediumscale enterprises that hold minor shares. The leaders of the global multiplexed diagnostics market in 2015 all showed a diverse product portfolio, the possession of advanced tech, and a wide area of regional presence. In a research report recently published by Transparency Market Research, the global multiplexed diagnostics market is expected to witness a high degree of competition over the coming years. This fact is primarily concluded from the high volume of smaller players in the market that are eyed by the fewer, larger ones in terms of partnerships, mergers, and acquisitions. Although the volume of smaller players in the global multiplexed diagnostics market currently is very high, the scope